In the same line, in 2 weeks time I set up some questions to them in regards to the TPP since the topic we will be covering is IPRs and bilateral and regional trade agreements. Apart from the obvious questions they need to deal with I ask them to see the two sides of the coin in this particular agreement. Indeed the information is two sided: “strong and effective protection and enforcement of IP rights” i.e. restrictive measures contained in it. For example it is said that the measures threaten the access to generic drugs and biosimilars, impose new trade conditions in the seed market, and restrict freedom of expression, among others. On the other hand, it is said that all IP “commitments are aligned with the Doha Declaration on TRIPS and Public Health, affirming the rights of countries to take measures to promote public health.” They need to understand that in a table on negotiations we need to see this: and is it to us in such table to establish a right balance? I asked them to look at Article 7 and 8 of the TRIPS (principles and objectives).

Will definitely tell you what a room packed with more than 10 nationalities will have to say...remembering that in the room there will be citizens from developed countries, developing ones and I believe one from a LDC. Definitely, worth hearing and excited to be part of the debate.